Cargando…
When fat goes down, prostate cancer is on the ropes
Reprogrammed lipid metabolism and persistent androgen receptor signaling commonly mark aggressive prostate cancer. We describe that targeting de-novo lipogenesis deprives prostate cancer cells of substrates and fuel, while inhibiting androgen receptor signaling. Our study uncovers the interplay betw...
Autores principales: | Zadra, Giorgia, Loda, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512936/ https://www.ncbi.nlm.nih.gov/pubmed/31131311 http://dx.doi.org/10.1080/23723556.2019.1595308 |
Ejemplares similares
-
Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015) -
Targeting mutagenesis in B cells: Phosphorylation goes beyond AID association
por: Mu, Yunxiang, et al.
Publicado: (2018) -
Treating cancer when pRb and p53 cannot be reactivated
por: Zhu, Liang
Publicado: (2015) -
Metagenomic insights into the plasma virome of Brazilian patients with prostate cancer
por: Luciola Zanette, Dalila, et al.
Publicado: (2023) -
When breast cancer cells start to fend the educational process of NK cells off
por: Mamessier, Emilie, et al.
Publicado: (2013)